Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 8,082 | Dovepress* | 6,781 | 673+ | 1,171 | 7,454 |
| PubMed Central* | 0 | 628 | 254 | 628 | |
| Totals | 6,781 | 1,301 | 1,425 | 8,082 | |
|
*Since 3 April 2017 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 1 | 0 | 0 | 2 | 3 |
View citations on PubMed Central and Google Scholar